Godshalk Welsh Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,320
| Closed | -$327K | – | 118 |
|
|
2021
Q1 | $327K | Sell |
7,320
-7,560
| -51% | -$338K | 0.23% | 98 |
|
|
2020
Q4 | $684K | Sell |
14,880
-3,920
| -21% | -$180K | 0.5% | 68 |
|
|
2020
Q3 | $885K | Buy |
18,800
+12
| +0.1% | +$565 | 0.75% | 51 |
|
|
2020
Q2 | $958K | Sell |
18,788
-332
| -2% | -$16.9K | 0.9% | 41 |
|
|
2020
Q1 | $906K | Sell |
19,120
-320
| -2% | -$15.2K | 0.98% | 38 |
|
|
2019
Q4 | $1.14M | Buy |
19,440
+80
| +0.4% | +$4.7K | 0.94% | 42 |
|
|
2019
Q3 | $1.03M | Buy |
19,360
+80
| +0.4% | +$4.27K | 0.91% | 44 |
|
|
2019
Q2 | $964K | Buy |
19,280
+600
| +3% | +$30K | 0.89% | 43 |
|
|
2019
Q1 | $976K | Buy |
18,680
+1,080
| +6% | +$56.4K | 0.94% | 41 |
|
|
2018
Q4 | $841K | Buy |
17,600
+480
| +3% | +$22.9K | 0.94% | 42 |
|
|
2018
Q3 | $860K | Buy |
17,120
+240
| +1% | +$12.1K | 0.84% | 45 |
|
|
2018
Q2 | $851K | Hold |
16,880
| – | – | 0.89% | 44 |
|
|
2018
Q1 | $824K | Buy |
16,880
+840
| +5% | +$41K | 0.89% | 45 |
|
|
2017
Q4 | $711K | Sell |
16,040
-3,240
| -17% | -$144K | 0.72% | 56 |
|
|
2017
Q3 | $978K | Hold |
19,280
| – | – | 0.98% | 36 |
|
|
2017
Q2 | $1.04M | Sell |
19,280
-200
| -1% | -$10.8K | 1.03% | 34 |
|
|
2017
Q1 | $1.03M | Sell |
19,480
-320
| -2% | -$16.9K | 1.01% | 37 |
|
|
2016
Q4 | $953K | Buy |
19,800
+2,520
| +15% | +$121K | 0.98% | 34 |
|
|
2016
Q3 | $932K | Buy |
17,280
+1,040
| +6% | +$56.1K | 0.96% | 36 |
|
|
2016
Q2 | $880K | Sell |
16,240
-40
| -0.2% | -$2.17K | 0.93% | 36 |
|
|
2016
Q1 | $825K | Buy |
16,280
+160
| +1% | +$8.11K | 0.85% | 40 |
|
|
2015
Q4 | $813K | Buy |
16,120
+2,560
| +19% | +$129K | 0.85% | 38 |
|
|
2015
Q3 | $652K | Buy |
13,560
+800
| +6% | +$38.5K | 0.71% | 54 |
|
|
2015
Q2 | $664K | Buy |
12,760
+1,760
| +16% | +$91.6K | 0.67% | 61 |
|
|
2015
Q1 | $635K | Buy |
11,000
+1,200
| +12% | +$69.3K | 0.65% | 62 |
|
|
2014
Q4 | $524K | Buy |
+9,800
| New | +$524K | 0.48% | 73 |
|